156 related articles for article (PubMed ID: 1735078)
21. Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
Greco FA; Figlin R; York M; Einhorn L; Schilsky R; Marshall EM; Buys SS; Froimtchuk MJ; Schuller J; Schuchter L; Buyse M; Ritter L; Man A; Yap AK
J Clin Oncol; 1996 Oct; 14(10):2674-81. PubMed ID: 8874326
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.
Kim J; Zhi J; Satoh H; Koss-Twardy SG; Passe SM; Patel IH; Pazdur R
Anticancer Drugs; 1998 Sep; 9(8):689-96. PubMed ID: 9823427
[TBL] [Abstract][Full Text] [Related]
23. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma.
Wadler S; Gleissner B; Hilgenfeld RU; Thiel E; Haynes H; Kaleya R; Rozenblit A; Kreuser ED
Eur J Cancer; 1996 Jun; 32A(7):1254-6. PubMed ID: 8758262
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.
Wadler S; Lembersky B; Atkins M; Kirkwood J; Petrelli N
J Clin Oncol; 1991 Oct; 9(10):1806-10. PubMed ID: 1919631
[TBL] [Abstract][Full Text] [Related]
26. Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.
Figlin RA; Belldegrun A; Moldawer N; Zeffren J; deKernion J
J Clin Oncol; 1992 Mar; 10(3):414-21. PubMed ID: 1482425
[TBL] [Abstract][Full Text] [Related]
27. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
Seymour MT; Johnson PW; Hall MR; Wrigley PF; Slevin ML
Br J Cancer; 1994 Oct; 70(4):719-23. PubMed ID: 7917927
[TBL] [Abstract][Full Text] [Related]
28. Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma.
Ragnhammar P; Blomgren H; Edler D; Lundell G; Magnusson I; Sonnenfeld T
Eur J Cancer; 1995; 31A(3):315-20. PubMed ID: 7786594
[TBL] [Abstract][Full Text] [Related]
29. Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study.
Haarstad H; Jacobsen AB; Schjølseth SA; Risberg T; Fosså SD
Ann Oncol; 1994 Mar; 5(3):245-8. PubMed ID: 8186172
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
Pazdur R; Ajani JA; Patt YZ; Winn R; Jackson D; Shepard B; DuBrow R; Campos L; Quaraishi M; Faintuch J
J Clin Oncol; 1990 Dec; 8(12):2027-31. PubMed ID: 2230894
[TBL] [Abstract][Full Text] [Related]
31. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
[TBL] [Abstract][Full Text] [Related]
32. Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancer.
Preiss J
Semin Oncol; 1992 Apr; 19(2 Suppl 3):220-4. PubMed ID: 1557652
[TBL] [Abstract][Full Text] [Related]
33. Double 5-fluorouracil modulation with folinic acid and recombinant alpha-2B-interferon. A phase I-II study in metastatic colorectal cancer patients.
Brunetti I; Falcone A; Bertuccelli M; Cianci C; Ricci S; Conte PF
Am J Clin Oncol; 1994 Jun; 17(3):210-4. PubMed ID: 8192103
[TBL] [Abstract][Full Text] [Related]
34. A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.
Shapiro JD; Harold N; Takimoto C; Hamilton JM; Vaughn D; Chen A; Steinberg SM; Liewehr D; Allegra C; Monahan B; Lash A; Grollman F; Flemming D; Behan K; Johnston PG; Haller D; Quinn M; Morrison G; Grem JL
Clin Cancer Res; 1999 Sep; 5(9):2399-408. PubMed ID: 10499610
[TBL] [Abstract][Full Text] [Related]
35. Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.
Kelsen D; Lovett D; Wong J; Saltz L; Buckley M; Murray P; Heelan R; Lightdale C
J Clin Oncol; 1992 Feb; 10(2):269-74. PubMed ID: 1732428
[TBL] [Abstract][Full Text] [Related]
36. A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
Piga A; Cascinu S; Latini L; Marcellini M; Bavosi M; Acito L; Bascioni R; Giustini L; Francini G; Pancotti A; Rossi G; Del Papa M; Carle F; Cellerino R
Br J Cancer; 1996 Sep; 74(6):971-4. PubMed ID: 8826868
[TBL] [Abstract][Full Text] [Related]
37. Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.
Kemeny N; Younes A; Seiter K; Kelsen D; Sammarco P; Adams L; Derby S; Murray P; Houston C
Cancer; 1990 Dec; 66(12):2470-5. PubMed ID: 2249187
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-alpha-2a in patients with advanced malignancies.
Wadler S; Haynes H; Schechner R; Rozenblit A; Wiernik PH
Invest New Drugs; 1996; 13(4):315-20. PubMed ID: 8824349
[TBL] [Abstract][Full Text] [Related]
39. Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
Kaubisch A; Kaleya R; Haynes H; Rozenblit A; Wadler S
Cancer Chemother Pharmacol; 2004 Apr; 53(4):337-40. PubMed ID: 14704829
[TBL] [Abstract][Full Text] [Related]
40. A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Knauf WU; Boese-Landgraf J; Schalhorn A; Zeitz M
Semin Oncol; 1992 Apr; 19(2 Suppl 3):197-203. PubMed ID: 1557647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
